Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental study

15 Sept 2021

Abstract excerpt

BACKGROUND AND AIMS: Non-alcoholic fatty liver disease (NAFLD) has become a common chronic liver disease in the world. Simple steatosis (SS) is the early phase of NAFLD. However, the molecular mechanisms underlying the development of steatosis have not yet been fully elucidated. METHODS: Two public datasets (GSE48452 and GSE89632) through the Gene Expression Omnibus (GEO) database were used to identify...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adipose Tissue and Metabolism
Share to Growth Hormone and Insulin-like Growth Factors
Share to Liver Disease Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34524971
DOI: 10.1530/ec-21-0353

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

IGFBP-2 as a biomarker in NAFLD improves hepatic steatosis: an integrated bioinformatics and experimental studyPMID 34524971Read ↗

Bioinformatics analysis of differentially expressed genes in non alcoholic fatty liver disease using next generation sequencing dataSemantic proximity Read ↗

Identification of key genes in non‑alcoholic fatty liver disease progression based on bioinformatics analysis.Semantic proximity Read ↗

Candidate genes investigation for severe nonalcoholic fatty liver disease based on bioinformatics analysisSemantic proximity Read ↗

Identification of Shared Gene Signatures in Different Stages of Non-Alcoholic Fatty Liver Disease Using Integrated Microarray DatasetSemantic proximity Read ↗

Investigation of the pathogenesis of liver cirrhosis associated with type 2 diabetes mellitus via bioinformatic analysisSemantic proximity Read ↗

CXCL9, IL2RB, and SPP1, potential diagnostic biomarkers in the co-morbidity pattern of atherosclerosis and non-alcoholic steatohepatitisSemantic proximity Read ↗

Machine learning-based identification of key lipid metabolism-related genes and associated ceRNA networks in NAFLDSemantic proximity Read ↗

Integration analysis identifies the role of metallothionein in the progression from hepatic steatosis to steatohepatitisSemantic proximity Read ↗

Comprehensive analysis of endoplasmic reticulum-related and secretome gene expression profiles in the progression of non-alcoholic fatty liver diseaseSemantic proximity Read ↗

Integrated Analysis of Multiple Microarray Studies to Identify Novel Gene Signatures in Non-alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

Key genes associated with non-alcoholic fatty liver disease and hepatocellular carcinoma with metabolic risk factorsSemantic proximity Read ↗

Identification and Analysis of Pivotal Genes in Type 2 Diabetes Mellitus Combined With Non-Alcoholic Fatty Liver DiseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.